Edwards Lifesciences Corporation EW

86.29 0.56 0.65% as of 25 Sep
Market cap
$49.4B
P/E
49.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Edwards Lifesciences Corporation (EW) Operating margin

Edwards Lifesciences Corporation's operating margin over the twelve months to 30 June 2026 was 22.3%, up 1.4 percentage points from fiscal 2025 (20.8%). Over the past ten years it has ranged from 20.1% (fiscal 2018) to 33.6% (fiscal 2022); the current reading is higher than 27% of that period. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 20.8% (4.51)
FY2024 25.4% (0.78)
FY2023 26.1% (7.44)
FY2022 33.6% 1.27
FY2021 32.3% 11.84
FY2020 20.5% (5.92)
FY2019 26.4% 6.28
FY2018 20.1% (11.61)
FY2017 31.7% 5.26
FY2016 26.5% 0.68

Quarterly

Period Operating margin Change (points)
Jun 2026 29.5% 0.51
Mar 2026 29.0% 19.34
Dec 2025 9.63% (10.14)
Sep 2025 19.8% (7.07)
42 more quarters

Against its own ten years

Low 20.1% High 33.6%
Ten-year median 26.1%
Current reading's percentile 27

Operating margin against peers

Company Operating margin
DXCM DexCom, Inc. compare 22.9%
EW Edwards Lifesciences Corporation 22.3%
SYK Stryker Corporation compare 21.4%
BSX Boston Scientific Corporation compare 19.8%
STE STERIS plc compare 18.9%
MDT Medtronic PLC compare 18.1%
ZBH Zimmer Biomet Holdings, Inc. compare 14.2%
GEHC GE HealthCare Technologies Inc. compare 12.9%
PHG Koninklijke Philips N.V. compare 9.64%
Medical Devices industry median −15.0%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on EW